Drug Profile
Research programme: ophthalmic analgesic - D.Western Therapeutics Institute
Latest Information Update: 29 Sep 2023
Price :
$50
*
At a glance
- Originator Unknown
- Developer D. Western Therapeutics Institute
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Preoperative pain
Most Recent Events
- 29 Sep 2023 Discontinued - Preclinical for Preoperative pain in Japan (unspecified route) (D.Western Therapeutics Institute website; September 2023)
- 28 Jul 2019 No recent reports of development identified for preclinical development in Preoperative pain in Japan